Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 196

    1.

    Treatment satisfaction with inhaled insulin in patients with type 1 diabetes: a randomized controlled trial.

    Gerber RA, Cappelleri JC, Kourides IA, Gelfand RA.

    Diabetes Care. 2001 Sep;24(9):1556-9.PMID: 11522698 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen.

    Cappelleri JC, Cefalu WT, Rosenstock J, Kourides IA, Gerber RA.

    Clin Ther. 2002 Apr;24(4):552-64.PMID: 12017400 [PubMed - indexed for MEDLINE]Related articles

    3.

    Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.

    Rosenstock J, Cappelleri JC, Bolinder B, Gerber RA.

    Diabetes Care. 2004 Jun;27(6):1318-23.PMID: 15161782 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: results of a 6-month, randomized, comparative trial.

    Quattrin T, Bélanger A, Bohannon NJ, Schwartz SL; Exubera Phase III Study Group.

    Diabetes Care. 2004 Nov;27(11):2622-7.PMID: 15504996 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effect of inhaled insulin on patient-reported outcomes and treatment preference in patients with type 1 diabetes.

    Hayes RP, Muchmore D, Schmitke J.

    Curr Med Res Opin. 2007 Feb;23(2):435-42.PMID: 17288697 [PubMed - indexed for MEDLINE]Related articles

    6.

    Satisfaction and quality of life with premeal inhaled versus injected insulin in adolescents and adults with type 1 diabetes.

    Testa MA, Simonson DC.

    Diabetes Care. 2007 Jun;30(6):1399-405. Epub 2007 Mar 2.PMID: 17337493 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes.

    Cappelleri JC, Gerber RA, Kourides IA, Gelfand RA.

    Diabetes Care. 2000 Dec;23(12):1799-803.PMID: 11128356 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Intensive therapy with inhaled insulin via the AERx insulin diabetes management system: a 12-week proof-of-concept trial in patients with type 2 diabetes.

    Hermansen K, Rönnemaa T, Petersen AH, Bellaire S, Adamson U.

    Diabetes Care. 2004 Jan;27(1):162-7.PMID: 14693983 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.

    DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ; Dutch Insulin Pump Study Group.

    Diabetes Care. 2002 Nov;25(11):2074-80.PMID: 12401759 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial.

    Skyler JS, Weinstock RS, Raskin P, Yale JF, Barrett E, Gerich JE, Gerstein HC; Inhaled Insulin Phase III Type 1 Diabetes Study Group.

    Diabetes Care. 2005 Jul;28(7):1630-5.PMID: 15983312 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.

    Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, Hendler R, Lan SP, Cefalu WT.

    Ann Intern Med. 2005 Oct 18;143(8):549-58.PMID: 16230721 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial.

    Hollander PA, Blonde L, Rowe R, Mehta AE, Milburn JL, Hershon KS, Chiasson JL, Levin SR.

    Diabetes Care. 2004 Oct;27(10):2356-62.PMID: 15451900 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Efficacy of inhaled human insulin in type 1 diabetes mellitus: a randomised proof-of-concept study.

    Skyler JS, Cefalu WT, Kourides IA, Landschulz WH, Balagtas CC, Cheng SL, Gelfand RA.

    Lancet. 2001 Feb 3;357(9253):331-5.PMID: 11210993 [PubMed - indexed for MEDLINE]Related articles

    15.

    Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus.

    Ceglia L, Lau J, Pittas AG.

    Ann Intern Med. 2006 Nov 7;145(9):665-75.PMID: 17088580 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.

    Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D.

    Ann Intern Med. 2008 Oct 21;149(8):531-9.PMID: 18936501 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Improvement of diabetic control and acceptability of a three-injection insulin regimen in diabetic adolescents. A multicenter controlled study.

    Bougnères PF, Landais P, Mairesse AM, Jais JP, Jos J, Peyraud J, Wieliczko MC, Chavoix P, Garandeau P, Asensi D, et al.

    Diabetes Care. 1993 Jan;16(1):94-102.PMID: 8422839 [PubMed - indexed for MEDLINE]Related articles

    18.

    A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

    Herman WH, Ilag LL, Johnson SL, Martin CL, Sinding J, Al Harthi A, Plunkett CD, LaPorte FB, Burke R, Brown MB, Halter JB, Raskin P.

    Diabetes Care. 2005 Jul;28(7):1568-73.PMID: 15983302 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.

    Tîrgovişte CI, Străchinariu R, Farcaşiu E, Milicevic Z, Teodorescu G.

    Rom J Intern Med. 2003;41(2):153-62.PMID: 15526500 [PubMed - indexed for MEDLINE]Related articles

    20.

    Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens.

    Chancellor J, Aballéa S, Lawrence A, Sheldon R, Cure S, Plun-Favreau J, Marchant N.

    Pharmacoeconomics. 2008;26(3):217-34.PMID: 18282016 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data